Page last updated: 2024-08-24

triazoles and Bone Fractures

triazoles has been researched along with Bone Fractures in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's18 (66.67)29.6817
2010's9 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boccardo, F; Bordonaro, R; Fini, A; Guglielmini, P; Massidda, B; Orzalesi, L; Porpiglia, M; Roagna, R; Rubagotti, A; Serra, P; Ucci, G1
Ingle, JN1
Badovinac-Crnjevic, T; Chalchal, H; Chapman, JA; Cheung, AM; Elliott, CR; Goss, PE; Hershman, DL; Ingle, JN; Khosla, S; Linden, HM; Muss, HB; Pritchard, KI; Rowland, K; Scher, J; Shepherd, LE; St Louis, J; Stearns, V1
Chen, WB; Dong, W; Feng, WJ; Li, ZX; Ma, CY; Ou-Yang, ZJ1
Vestergaard, P1
Brown, JE; Coleman, RE; Dodwell, D; Ellis, SP; Gutcher, SA; Hannon, RA; Horsman, JM; Lester, JE; Purohit, OP; Thorpe, R1
Kim, SJ; Noguchi, S; Okishiro, M; Shimazu, K; Taguchi, T; Tamaki, Y; Tanji, Y1
Bellemore, MC; Ellis, DH; Kesson, AM; O'Mara, TJ; Sorrell, TC1
Campone, M; Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Forbes, JF; Gelber, RD; Goldhirsch, A; Hawle, H; Láng, I; Mouridsen, H; Nogaret, JM; Paridaens, RJ; Pienkowski, T; Price, KN; Rabaglio, M; Smith, I; Sun, Z; Thürlimann, B1
Ando, M; Baba, S; Dokiya, F; Douchi, T; Kosha, S; Matsuyama, Y; Ohi, Y; Rai, Y; Sagara, Y; Tamada, S1
Coates, AS; Forbes, J; Gelber, RD; Giobbie-Hurder, A; Goldhirsch, A; Mauriac, L; Mouridsen, H; Paridaens, R; Price, KN; Regan, MM; Smith, I; Thürlimann, B1
Apffelstaedt, JP; Barlow, D; Campone, M; Clack, G; Eastell, R; Hannon, RA; Mackey, JR; Makris, A; Van Poznak, C1
Bhagwat, K; Brooks, M; Eisen, D; Royse, A; Royse, C; Sparks, P1
Balakrishnan, A; Ravichandran, D1
Futsuhara, K; Kai, T; Kojima, M; Tabei, T; Takei, H; Takeuchi, H; Yoshida, T1
Aumiller, J1
Denes, AE1
Adams, JE; Clack, G; Cuzick, J; Dowsett, M; Eastell, R; Hannon, RA1
Lønning, PE1
Chien, AJ; Goss, PE1
Angeli, A; Ardine, M; Berruti, A; Bertoldo, F; Dogliotti, L; Mosca, A; Tucci, M; Vana, F1
Bell, R; Lewis, J1
Gralow, JR1
Brun, J; Confavreux, CB; Delmas, PD; Fontana, A; Guastalla, JP; Munoz, F1
Baum, M; Buzdar, A; Cuzick, J; Forbes, JF; Howell, A; Tobias, JS1
Toi, M1
Castiglione-Gertsch, M; Chirgwin, JH; Coates, AS; Colleoni, M; Crivellari, D; Del Mastro, L; Forbes, JF; Gelber, RD; Gladieff, L; Goldhirsch, A; Láng, I; Mauriac, L; Mouridsen, H; Paridaens, RJ; Price, KN; Rabaglio, M; Smith, IE; Sun, Z; Thürlimann, B1

Reviews

4 review(s) available for triazoles and Bone Fractures

ArticleYear
Postmenopausal women with hormone receptor-positive breast cancer: balancing benefit and toxicity from aromatase inhibitors.
    Breast (Edinburgh, Scotland), 2013, Volume: 22 Suppl 2

    Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Chemotherapy, Adjuvant; Drug-Related Side Effects and Adverse Reactions; Estrogen Antagonists; Female; Follow-Up Studies; Fractures, Bone; Humans; Letrozole; Mastectomy, Segmental; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles

2013
Skeletal effects of drugs to treat cancer.
    Current drug safety, 2008, Volume: 3, Issue:3

    Topics: Anastrozole; Animals; Antineoplastic Agents; Aromatase Inhibitors; Bone Density; Bone Diseases, Metabolic; Fractures, Bone; Humans; Neoplasms; Nitriles; Triazoles

2008
Bone safety of aromatase inhibitors versus tamoxifen.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2006, Volume: 16 Suppl 2

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Female; Fractures, Bone; Humans; Letrozole; Nitriles; Postmenopause; Tamoxifen; Triazoles

2006
Aromatase inhibitors and bone health in women with breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Nov-20, Volume: 24, Issue:33

    Topics: Absorptiometry, Photon; Algorithms; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Remodeling; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Life Style; Neoplasms, Hormone-Dependent; Nitriles; Osteoporosis, Postmenopausal; Population Surveillance; Risk Factors; Triazoles

2006

Trials

11 trial(s) available for triazoles and Bone Fractures

ArticleYear
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: long term results of the Italian Tamoxifen Anastrozole trial.
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:7

    Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Endometrial Neoplasms; Female; Follow-Up Studies; Fractures, Bone; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Risk Factors; Tamoxifen; Time Factors; Treatment Outcome; Triazoles

2013
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.
    The Lancet. Oncology, 2014, Volume: 15, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bones of Lower Extremity; Breast Neoplasms; Calcium; Canada; Chemotherapy, Adjuvant; Dietary Supplements; Diphosphonates; Female; Fractures, Bone; Humans; Lumbar Vertebrae; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Radiography; Time Factors; Treatment Outcome; Triazoles; United States; Vitamin D

2014
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Oct-01, Volume: 14, Issue:19

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Diseases; Breast Neoplasms; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Ibandronic Acid; Lumbar Vertebrae; Middle Aged; Nitriles; Placebos; Triazoles

2008
Incidence of joint symptoms and bone fractures in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole.
    Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:6

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Asian People; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fractures, Bone; Humans; Incidence; Japan; Joint Diseases; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles; White People

2009
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:9

    Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Double-Blind Method; Female; Fractures, Bone; Humans; Incidence; Letrozole; Middle Aged; Nitriles; Postmenopause; Risk Factors; Tamoxifen; Triazoles

2009
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
    The New England journal of medicine, 2009, Aug-20, Volume: 361, Issue:8

    Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Kaplan-Meier Estimate; Letrozole; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Proportional Hazards Models; Tamoxifen; Triazoles

2009
Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-20, Volume: 28, Issue:6

    Topics: Aged; Anastrozole; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Double-Blind Method; Etidronic Acid; Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Middle Aged; Neoplasm Staging; Nitriles; Osteoporosis, Postmenopausal; Postmenopause; Prognosis; Risedronic Acid; Survival Rate; Treatment Outcome; Triazoles

2010
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2006, Volume: 21, Issue:8

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Biomarkers; Bone Density; Bone Remodeling; Breast Neoplasms; Female; Fractures, Bone; Hip; Humans; Lumbar Vertebrae; Middle Aged; Nitriles; Postmenopause; Radiography; Risk; Tamoxifen; Triazoles

2006
Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Bone, 2007, Volume: 41, Issue:3

    Topics: Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Collagen Type I; Diphosphonates; Estradiol; Female; Fractures, Bone; Humans; Middle Aged; Nitriles; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Triazoles

2007
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
    The Lancet. Oncology, 2008, Volume: 9, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Alkylating; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Follow-Up Studies; Fractures, Bone; Humans; Neoplasm Recurrence, Local; Nitriles; Postmenopause; Tamoxifen; Time Factors; Triazoles

2008
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Apr-20, Volume: 26, Issue:12

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cardiovascular Diseases; Double-Blind Method; Female; Fractures, Bone; Humans; Letrozole; Middle Aged; Nitriles; Patient Compliance; Postmenopause; Tamoxifen; Triazoles

2008

Other Studies

12 other study(ies) available for triazoles and Bone Fractures

ArticleYear
Photoluminescence and labelling for microcrack bone of N-salicylidene-3-amino-1,2,4-triazole.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2015, Feb-05, Volume: 136 Pt C

    Topics: Amitrole; Bone and Bones; Diagnostic Imaging; Fluorescence; Fractures, Bone; Microscopy, Confocal; Schiff Bases; Spectrometry, Fluorescence; Staining and Labeling; Triazoles

2015
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, May-01, Volume: 48, Issue:9

    Topics: Antifungal Agents; Child; Drug Therapy, Combination; Female; Fractures, Bone; Humans; Mycoses; Naphthalenes; Osteomyelitis; Phosphorylcholine; Pyrimidines; Scedosporium; Terbinafine; Treatment Outcome; Triazoles; Voriconazole; Wounds and Injuries

2009
Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients.
    Breast cancer (Tokyo, Japan), 2010, Volume: 17, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Aromatase Inhibitors; Arthralgia; Bone Density; Breast Neoplasms; Cerebral Infarction; Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Japan; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Survival Rate; Treatment Outcome; Triazoles

2010
An accidental mass.
    Lancet (London, England), 2011, May-21, Volume: 377, Issue:9779

    Topics: Accidents, Traffic; Adult; Aspergillus flavus; Caspofungin; Combined Modality Therapy; Coronary Thrombosis; Diagnosis, Differential; Disease Progression; Echinocandins; Echocardiography; Echocardiography, Transesophageal; Embolism; Emergency Service, Hospital; Endocarditis; Female; Fractures, Bone; Humans; Incidental Findings; Invasive Pulmonary Aspergillosis; Lipopeptides; Mediastinal Diseases; Pelvic Bones; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy.
    British journal of cancer, 2011, Dec-06, Volume: 105, Issue:12

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Fractures, Bone; Humans; Letrozole; Middle Aged; Nitriles; Survival Analysis; Triazoles

2011
A multicenter prospective study to evaluate bone fracture related to adjuvant anastrozole in Japanese postmenopausal women with breast cancer: two-year interim analysis of Saitama Breast Cancer Clinical Study Group (SBCCSG-06).
    International journal of clinical oncology, 2014, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Bone Density; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fractures, Bone; Humans; Japan; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles

2014
[Breast carcinoma: new, much promising trends. The cancer anxiety of women -- will be taken better care soon?].
    MMW Fortschritte der Medizin, 2005, Mar-10, Volume: 147, Issue:10

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Austria; Breast Neoplasms; Clinical Trials as Topic; Female; Fractures, Bone; Germany; Humans; Mammography; Middle Aged; Multicenter Studies as Topic; Nitriles; Osteoporosis; Randomized Controlled Trials as Topic; Risk; Risk Factors; Tamoxifen; Time Factors; Triazoles

2005
Case 24-2005: a woman with estrogen-receptor-positive breast cancer.
    The New England journal of medicine, 2005, Nov-24, Volume: 353, Issue:21

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Diseases, Metabolic; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fractures, Bone; Humans; Nitriles; Receptors, Estrogen; Tamoxifen; Triazoles

2005
Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Apr-10, Volume: 25, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers; Bone Density; Breast Neoplasms; Canada; Chemotherapy, Adjuvant; Collagen Type I; Estrogen Receptor Modulators; Female; Fractures, Bone; Humans; Letrozole; Middle Aged; Nitriles; Peptides; Tamoxifen; Treatment Outcome; Triazoles

2007
Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.
    Current medical research and opinion, 2007, Volume: 23, Issue:5

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colles' Fracture; Female; Fractures, Bone; Humans; Middle Aged; Nitriles; Postmenopause; Risk Assessment; Tamoxifen; Triazoles; Wrist Injuries

2007
Bone density in breast cancer: when to intervene?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-01, Volume: 25, Issue:22

    Topics: Absorptiometry, Photon; Anastrozole; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Goserelin; Humans; Imidazoles; Nitriles; Osteoporosis; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles; Zoledronic Acid

2007
Long-term outcomes of aromatase inhibition for breast cancer.
    The Lancet. Oncology, 2008, Volume: 9, Issue:1

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Female; Follow-Up Studies; Fractures, Bone; Humans; Nitriles; Postmenopause; Survival Analysis; Tamoxifen; Time Factors; Triazoles

2008